Faruqi and Faruqui, LLP Logo
Share this page

Osiris Therapeutics, Inc. (OSIR)

NASDAQ:OSIR

Summary

Faruqi & Faruqi, LLP Announces an Investigation of Osiris Therapeutics, Inc. (OSIR) Over the Proposed Merger of the Company with Smith & Nephew plc

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating the proposed merger of Osiris Therapeutics, Inc. (“OSIRIS” or the “Company”) (NASDAQ:OSIR) with Smith & Nephew plc.

For more information, please fill out the form below.  There is no cost or obligation to you.

The firm’s investigation focuses on whether Osiris and its Board of Directors violated federal securities laws and/or breached fiduciary duties in relation to the proposed transaction with Smith & Nephew plc., including whether the solicitation material is misleading and whether the merger consideration undervalues the Company to the detriment of Osiris’s shareholders.

If you own common stock in Osiris and wish to obtain free of charge additional information about this investigation regarding your investments, please fill out the form below.  You can also contact James M. Wilson, Jr., Esq. either via e-mail at jwilson@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    Osiris Therapeutics, Inc. (OSIR)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Nadeem Faruqi
James M. Wilson, Jr.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 03/27/2019

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.